While the medical-device stock highlighted in today’s article is up nearly 20% this year, it lags the S&P 500 and the core medical-device exchange-traded fund. Why? The firm faces several headwinds, including a strong U.S. dollar and heightened scrutiny surrounding one of its products. But these headwinds may be causing investors to overlook a solid company poised to outperform, with one analyst saying the following: “Put up double-digit earnings, add the dividend yield, and you’ll end up with a return in the low double digits to low teens. That’s what this stock is set up to do.” For more, CLICK HERE.